Results 151 to 160 of about 884,292 (292)
Italian Patients Journey for Gene Therapy in Haemophilia A
ABSTRACT Introduction Gene therapy (GT) provides sustained FVIII levels without repeated infusions in Hemophilia A (HA) patients thus overcoming a major limitation of replacement therapy. However, issues remain e.g., patient selection criteria, duration and variability of transgene expression, quality of life and long‐term safety.
Giovanni Di Minno +19 more
wiley +1 more source
Serum alpha fetoprotein in childhood
A I Berkel, F Ersoy, N Cevik, N Koçak
doaj
Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations. [PDF]
Parikh ND +11 more
europepmc +1 more source
ABSTRACT Aim To evaluate the frequency, imaging characteristics, associated factors, and clinical significance of biliary abnormalities on imaging in patients receiving lenvatinib (LEN) plus cisplatin hepatic arterial infusion chemotherapy (HAIC) for hepatocellular carcinoma (HCC).
Hirohito Osanai +10 more
wiley +1 more source
Alpha-Fetoprotein Is a Potential Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC): A Case Report. [PDF]
Zhong K +7 more
europepmc +1 more source
Alpha1-fetoprotein in neonatal jaundice
ArticleThe original publication is available at http://www.samj.org.zaThe relationship between the concentration of alphal-fetoprotein (AFP) in cord blood and neonatal jaundice has been examined in 259 neonates.
Odendaal , H. J. +3 more
core
Among patients with CP‐A HCC initially within the Japan criteria, some lose oncological eligibility for LT before hepatic decompensation. Further studies are needed to identify baseline factors associated with poor outcomes and to evaluate their relevance to future LT candidacy.
Akihiro Seki +16 more
wiley +1 more source
Alpha-Fetoprotein as a Biomarker in Pregnancy: From Genetic Disorders to Obstetric Complications. [PDF]
Musawi S.
europepmc +1 more source
We carried out proteomic analysis of serum extracellular vesicles to identify biomarkers predictive of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis B receiving nucleos(t)ide analog therapy. Candidate proteins identified through proteomic analysis were subsequently quantified in serum by ELISA.
Emi Sometani +21 more
wiley +1 more source

